This new Institute for New Economic Thinking (INET) blog piece by AIRnet researchers William Lazonick and Öner Tulum explores the complex issue of drug pricing, particularly the ongoing negotiations between Medicare and pharmaceutical companies. In this blog piece based on…
Tag: financialization
Elon Musk and Tesla Shape America’s Future, but Problems Run Deeper than Tweets
In this insightful INET blog piece, Lynn Parramore interviews AIRnet President William Lazonick about Tesla’s role in shaping America’s future. Drawing on Lazonick and Matt Hopkins’ INET-funded working paper, “Tesla as a Global Competitor: Strategic Control in the EV Transition,”…
The British Academy Conference on “Resolving Global Vaccine Inequity: Innovation, Capabilities and Governance” co-organized by SOAS and AIRNET
On April 11-12, 2024, SOAS University of London and the Academic-Industry Research Network, co-hosted the British Academy Conference on “Resolving Global Vaccine Inequity: Innovation, Capabilities and Governance” to gather biomedical and social scientists, public health practitioners, and policy makers to…
The Real Book About the “White Working Class”
In a Racket News interview with Matt Taibbi, Les Leopold, Executive Director of the Labor Institute and an associate of the Academic-Industry Research Network, discusses his latest book, Wall Street’s War on Workers.
Experts: Negotiating Big Pharma’s Prices Won’t Stifle Innovation—They Don’t Use the Money to Innovate!
Lynn Parramore explains how physician-scientist Fred Ledley and economist William Lazonick debunked the arguments of “industry lobbyists vehemently oppose Medicare drug price negotiations”. Click HERE to read the article at www.ineteconomics.org.
Creating value or extracting it? An existential question.
In her blog “Thought Sparks“, Rita McGrath quotes and cites Lazonick’s book, Investing in Innovation: Confronting Predatory Value Extraction in the U.S. Corporation, and discuses “a board and governance level issue that doesn’t get nearly enough attention is whether firms…
Investing in Innovation
Confronting Predatory Value Extraction in the U.S. Corporation by William Lazonick Business corporations interact with household units and government agencies to make investments in productive capabilities required to generate innovative goods and services. When they work harmoniously, these three types…
Shredding Paper
The Rise and Fall of Maine’s Mighty Paper Industry by Michael Hillard “From the early twentieth century until the 1960s, Maine led the nation in paper production. The state could have earned a reputation as the Detroit of paper production,…
The KPFA Evening News (interview with William Lazonick)
Interview of the president of TheAIRNet, William Lazonick, in KPFA evening news [Click HERE to listen the interview] via KPFA l by KPFA Evening News l October 10, 2020
Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry
By Öner Tulum & William Lazonick ◊ There are widespread claims that a productivity crisis afflicts the U.S. pharmaceutical industry despite the fact that the U.S. institutional environment provides unique advantages for drug R&D. We argue that the explanation for this productivity paradox is the “financialization” of the U.S. pharmaceutical industry. Driven by shareholder-value ideology, the U.S. pharmaceutical industry has adopted a highly financialized business model…
